RZRadomir Zivadinovic

Radomir Zivadinovic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Radomir Zivadinovic has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cervical cancer screening: Past, present and outlook

    by Radomir Živadinović, Aleksandra Petrić, Aleksandar Živadinović, Sonja Pop-Trajković, Lazar Živadinović, Dušan Simić

    Cervical cancer is the fourth most common carcinoma in women globally, following breast, lung and colon cancer. Primary prevention (vaccination) and secondary prevention (organised screening) in developed countries have made a significant difference in the structure of morbidity, as well as mortality from this disease, compared to undeveloped countries. The primary objective of cervical cancer screening is identification of abnormal epithelial cells that are likely to progress into invasive carcinoma (CIN II + and AIS) and that require surgical treatment, which reduces cervical cancer incidence and mortality. Secondary objective of screening is diagnosing early stages of invasive carcinoma (MIC) which also decreases cervical cancer morbidity and mortality. Cervical cancer screening strategy differs in different parts of the world and needs to be adapted to the methods that are available and reliable in the given country, and that allow for the best possible organisational arrangements and development of the infrastructure for cancer screening implementation and quality assurance, in line with specific human and financial resources available to the country


  • Open Access

    FEATURES OF ENDOCERVICAL ADENOCARCINOMA IN RELATION TO SQUAMOUS INTRAEPITHELIAL LESIONS AND SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX

    by Aleksandar Živadinović, Aleksandra Petrić, Biljana Živadinović, Dane Krtinić, Jelena Živadinović, Radomir Živadinović

  • Open Access

    Knowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia

    by Nataša K. Rančić, Milan B. Golubović, Mirko V. Ilić, Aleksanda S. Ignjatović, Radomir M. Živadinović, Saša N. Đenić, Stefan D. Momčilović, Biljana N. Kocić, Zoran G. Milošević, Suzana A. Otašević

    Background and objectives: Persistent infection with carcinogenic human papillomavirus (HPV) is the leading cause of cervical cancer. The study explored students’ knowledge about cervical cancer and awareness of human papillomavirus and the HPV vaccine. Materials and Methods: A questionnaire-based survey was carried out among 1616 first-year female college students at the University of Niš. It examined socio-demographic characteristics, measured the score of knowledge about cervical cancer, assessed awareness regarding HPV and the HPV vaccine and inquired about the source of information about cervical cancer and HPV. Results: The average cervical cancer knowledge score was 16.35 ± 7.92 (min 0, max 30), with medical professional education, parents’ education level, place of residence and relationship status having significant effects on the score. The awareness about HPV and the HPV vaccine was low, with only 14.2% of students having heard about both HPV and its vaccine. The most commonly reported sources of information were the media, while the most competent one was organized health education. Conclusions: Health promotion campaigns and educational programs are necessary in order to reduce cervical cancer burden and should be directed particularly towards those who have demonstrated low cervical cancer knowledge and low awareness regarding HPV and its vaccine.


  • T lymphocytes in the third trimester decidua in preeclampsia

    by Jelena Milosevic-Stevanovic, Miljan Krstic, Milan Stefanovic, Radomir Zivadinovic, Predrag Vukomanovic, Sonja Pop Trajkovic-Dinic, Slavica Stojnev

    The aim of study was to conduct immunohistochemical quantification of CD3+ and CD8+ decidual lymphocytes in preeclampsia. A study group included 30 cases of preeclampsia and a control group included 20 healthy pregnant women, all delivered by Cesarean section. Samples of placental bed were analyzed after immunohistochemical staining of CD45+, CD3+ and CD8+ cells. The group with preeclampsia included a significantly higher number of CD3+ (p < 0.01) and CD8+ (p < 0.05) T lymphocytes. It is certain that thebalance dysregulation of T cell of the immune milieu of deciduais of importance in etiopathogenesis and manifestations of preeclampsia.


  • Open Access

    Unruptured tubal pregnancy in early second trimester

    by Aleksandra Petric, Radomir Zivadinovic, Dejan Mitic, Predrag Vukomanovic, Milan Trenkic

    • 1 August 2018
      • Vol. 22  (16) , 5149-5155

    Significance of the Ki-67 proliferation index in the assessment of the therapeutic response to cisplatin-based chemotherapy in patients with advanced cervical cancer

    by D. Krtinic, R. Zivadinovic, Z. Jovic, S. Pesic, D. Mihailovic, L. Ristic, A. Cvetanovic, I Todorovska, N. Zivkovic, G. N. Rankovic, et al.

    OBJECTIVE: The purposes of this study were to examine the therapeutic response of advanced cervical cancerto Ki-67 proliferative index (Ki-67 PI) dependent cisplatin chemotherapy, and to determine KI-67 PI referential value that is expected to provides satisfactory therapeutic response of cervical cancer to cisplatin chemotherapy. PATIENTS AND METHODS: This prospective study enrolled 59 patients treated for cervical cancer at Clinic for Oncology, Clinical Center Nis, Serbia. According to the obtained Ki-67 PI values, patients were divided into three groups, and all the patients received the same cytostatic, cisplatin. Therapeutic response to chemotherapy was evaluated in relation to disease progression presence or absence and progression-free survival after a year follow-up since the first chemotherapy. RESULTS: Survival rate increases with an increase of Ki-67 PI by Kaplan-Meier survival analysis, meaning that survival rate is statistically significantly shorter in the group of patients with Ki-67 PI < 40% in comparison to patients from other two groups (p=0.010). Mann-Whitney test confirmed a statistically significant increase in survival rate among the groups of patients formed according to Ki-67 PI (p= 60%), moderate KI-67 PI (40-60%), and low Ki-67 PI (>= 40%).


  • Open Access

    Ascitic Fluid in Ovarian Carcinoma – From Pathophysiology to the Treatment

    by Radomir Živadinović, Aleksandra Petrić, Dane Krtinić, Sonja Pop- Trajković Dinić, Biljana Živadinović

    Due to low symptomatology, a lack of screening, and relatively complicated diagnostic procedures of ovarian carcinoma, more and more women are believed to visit their doctors in advanced stage of the disease, complicated with ascitic fluid. There is an increasing evidence that peritoneal cytology is a subjective assessment with certain percentage of false-positive and false-negative results that may cause application of unnecessary chemotherapy or nonapplication of necessary chemotherapy. Maximal cytoreductive surgery followed by intraperitoneal or systemic chemotherapy remains to be the gold standard in preventing ascites. Ascites is not only a symptom of a disease, but a specific microenvironment for formation and mediation of protumorigenic signals that control ovarian cancer progression, proliferation, invasion, anti-apoptosis, chemoresistance and tumor heterogeneity. Acellular cytokines and immunological factors influence ovarian cancer progression and its ability to prevent immune responses of the body and tumor reaction to chemotherapy. Ascites contributes to disease dissemination, changing its course and final outcomes. Management of patients with ascites and ovarian carcinoma is complex and often the goal of the treatment is to target palliative procedures. Multidisciplinary approach is necessary in the management of these patients. Further investigations of new drugs and immunomodulators are needed aiming at prolonged periods between relapses.


  • Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women

    by Tanja Nikolova, Radomir Zivadinovic, Nina Evtimovska, Violeta Klisarovska, Marko Stanojevic, Jadranka Georgievska, Natasha Nikolova

    Aim: This study is a comparison of human epididymis protein 4 (HE4) with cancer antigen 125 (CA125), using the Risk of Ovarian Malignancy Algorithm (ROMA), Copenhagen Index (CPH‐I), Risk of Malignancy Index (RMI) and Morphology Index (MI) to differentiate ovarian endometriosis from epithelial ovarian cancer (EOC) in premenopausal women.Methods: The study was performed at the University Clinic of Obstetrics and Gynecology in Skopje. One hundred and sixty‐four premenopausal patients were divided into three study groups, including ovarian endometriosis (37), other benign pelvic masses (57) and EOCs (11), and a control group (59). After ultrasonography, all subjects underwent blood sampling. Surgery and histological verification was performed. Pelvic masses were classified based on histological findings. Mann–Whitney, receiver operating characteristic‐area under the curve (AUC), sensitivity, specificity and Kruskal–Wallis tests were used for statistical analysis. The level of significance α was set at 5%.Results: For each of the tested markers, sensitivity, specificity and accuracy to distinguish ovarian endometriosis from EOC were as follows: HE4 (81.82%, 100%, 95.83%); CA125 (81.82%, 48.65%, 56.25%); ROMA (90.91%, 83.78%, 85.42%); CPH‐I (81.82%, 97.30%, 93.75%); RMI (90.91%, 35.14%, 47.92%); and MI (100%, 75.68%, 81.25%), respectively. The AUC for ovarian endometriosis compared to EOC for tested markers was as follows: HE4 (AUC = 0.934), CA125 (AUC = 0.821), ROMA (AUC = 0.929), CPH‐I (AUC = 0.924) and RMI (AUC = 0.880), respectively.Conclusion: HE4 and CPH‐I perform best to discriminate ovarian endometriosis from EOC in premenopausal women. MI has maximal sensitivity to detect EOC.


  • HIV AND AIDS IN PREGNANCY

    by Lidija Popović-Dragonjić, Miodrag Vrbić, Maja Jovanović, Radomir Živadinović, Dane Krtinić, Clinical Center Niš Clinic of Infectious Diseases

  • Analysis of the Menstrual Cycle Variabilities of the Human Epididymis Protein 4

    by T Nikolova, R Živadinović, N Nikolova, N Evtimovska, B Pavlovski, V Tofiloska